» Articles » PMID: 18981087

Cutting Edge: Programmed Death-1/programmed Death Ligand 1 Interaction Regulates the Induction and Maintenance of Invariant NKT Cell Anergy

Overview
Journal J Immunol
Date 2008 Nov 5
PMID 18981087
Citations 81
Authors
Affiliations
Soon will be listed here.
Abstract

Invariant NKT (iNKT) cells are a distinct subset of T lymphocytes that recognize glycolipid Ags. Upon TCR stimulation, iNKT cells promptly secrete a wide range of cytokines and therefore have been investigated as a target for immunotherapy. However, after primary activation, iNKT cells become hyporesponsive toward their ligand (anergy). The further mechanism behind iNKT cell anergy is poorly understood. We found that a low level of programmed death-1 (PD-1) was constitutively expressed on iNKT cells and that PD-1 expression was increased after stimulation and lasted at least 2 mo. Moreover, not only did blocking of the PD-1/PD ligand 1 (PD-L1) pathway prevent the induction of anergy in iNKT cells, but anergic iNKT cells also recovered responsiveness and these "rescued" cells efficiently mediated antitumor immunity. Our findings suggest that the PD-1/PD-L1 interaction is essential for the induction and maintenance of iNKT cell anergy.

Citing Articles

The basic biology of NK cells and its application in tumor immunotherapy.

Jiang P, Jing S, Sheng G, Jia F Front Immunol. 2024; 15:1420205.

PMID: 39221244 PMC: 11361984. DOI: 10.3389/fimmu.2024.1420205.


PD-1 checkpoint inhibition enhances the antilymphoma activity of CD19-CAR-iNKT cells that retain their ability to prevent alloreactivity.

Moraes Ribeiro E, Secker K, Nitulescu A, Schairer R, Keppeler H, Wesle A J Immunother Cancer. 2024; 12(1).

PMID: 38296597 PMC: 10831439. DOI: 10.1136/jitc-2023-007829.


The role of natural killer T cells in liver transplantation.

Zhao W, Li M, Song S, Zhi Y, Huan C, Lv G Front Cell Dev Biol. 2024; 11:1274361.

PMID: 38250325 PMC: 10796773. DOI: 10.3389/fcell.2023.1274361.


Targeting the MR1-MAIT cell axis improves vaccine efficacy and affords protection against viral pathogens.

Rashu R, Ninkov M, Wardell C, Benoit J, Wang N, Meilleur C PLoS Pathog. 2023; 19(6):e1011485.

PMID: 37384813 PMC: 10337970. DOI: 10.1371/journal.ppat.1011485.


The effect of blocking immune checkpoints LAG-3 and PD-1 on human invariant Natural Killer T cell function.

Balasko A, Kowatsch M, Graydon C, Lajoie J, Fowke K Sci Rep. 2023; 13(1):10082.

PMID: 37344517 PMC: 10284876. DOI: 10.1038/s41598-023-36468-8.